Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.0282 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0025 | 0.0282 | 1 |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.0007 | 0.0038 | 0.0076 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0734 | 1 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0019 | 0.0195 | 0.6617 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.0282 | 0.0779 |
Echinococcus granulosus | Smad4 | 0.0008 | 0.0048 | 0.001 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.0282 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.0282 | 1 |
Echinococcus multilocularis | Smad4 | 0.0008 | 0.0048 | 0.001 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0032 | 0.0372 | 0.0335 |
Onchocerca volvulus | 0.0048 | 0.0597 | 0.1667 | |
Brugia malayi | Pre-SET motif family protein | 0.0032 | 0.0372 | 0.1064 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0038 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0019 | 0.0195 | 0.4698 |
Mycobacterium tuberculosis | Peptide synthetase MbtE (peptide synthase) | 0.0007 | 0.0038 | 0.0546 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0032 | 0.0372 | 0.0335 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0195 | 0.05 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0282 | 0.0779 |
Brugia malayi | Pre-SET motif family protein | 0.0221 | 0.2972 | 0.9354 |
Schistosoma mansoni | survival motor neuron protein | 0.0048 | 0.0597 | 0.0561 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0025 | 0.0282 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0195 | 0.05 |
Brugia malayi | hypothetical protein | 0.0151 | 0.2006 | 0.6273 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0019 | 0.0195 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0195 | 0.05 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0008 | 0.0048 | 0.0031 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0025 | 0.0282 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.0282 | 0.0779 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0007 | 0.0038 | 1 |
Brugia malayi | hypothetical protein | 0.0236 | 0.3174 | 1 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0008 | 0.0048 | 0.001 |
Echinococcus multilocularis | smad | 0.0008 | 0.0048 | 0.001 |
Trichomonas vaginalis | antibiotic synthetase, putative | 0.0007 | 0.0038 | 0.0076 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0048 | 0.001 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.2006 | 0.6273 |
Schistosoma mansoni | Smad4 | 0.0008 | 0.0048 | 0.001 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0195 | 0.05 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0031 | 0.0356 | 0.0319 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0019 | 0.0195 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0032 | 0.0372 | 0.0335 |
Trypanosoma brucei | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0038 | 1 |
Brugia malayi | Smad1 | 0.0008 | 0.0048 | 0.0031 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.0372 | 0.0335 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD1 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0038 | 0.0546 |
Onchocerca volvulus | 0.0151 | 0.2006 | 0.5868 | |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD8 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0038 | 0.0546 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0025 | 0.0282 | 1 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0048 | 0.0031 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0007 | 0.0038 | 0.0546 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0048 | 0.0031 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.0282 | 0.0779 |
Leishmania major | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0038 | 0.1354 |
Mycobacterium tuberculosis | Peptide synthetase MbtF (peptide synthase) | 0.0007 | 0.0038 | 0.0546 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0372 | 0.0335 |
Trypanosoma cruzi | acetyl-CoA synthetase, putative | 0.0007 | 0.0038 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0048 | 0.001 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.0181 | 0.6071 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.0282 | 1 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0008 | 0.0048 | 0.001 |
Onchocerca volvulus | 0.0032 | 0.0372 | 0.0996 | |
Schistosoma mansoni | smad | 0.0008 | 0.0048 | 0.001 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0032 | 0.0372 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.0282 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.037 | 0.5014 | 1 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD10 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0038 | 0.0546 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0048 | 0.0031 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0025 | 0.0282 | 1 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0025 | 0.0282 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0008 | 0.0048 | 0.0031 |
Onchocerca volvulus | 0.0025 | 0.0282 | 0.0728 | |
Trichomonas vaginalis | set domain proteins, putative | 0.0252 | 0.3391 | 0.6763 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0008 | 0.0048 | 0.001 |
Mycobacterium ulcerans | hypothetical protein | 0.0025 | 0.0282 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0195 | 0.05 |
Leishmania major | acetyl-CoA synthetase, putative | 0.0007 | 0.0038 | 0.1354 |
Brugia malayi | MH2 domain containing protein | 0.0119 | 0.1571 | 0.4888 |
Mycobacterium tuberculosis | P-hydroxybenzoyl-AMP ligase FadD22 | 0.0007 | 0.0038 | 0.0546 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0236 | 0.3174 | 0.3148 |
Trypanosoma cruzi | long-chain-fatty-acid-CoA ligase, putative | 0.0007 | 0.0038 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0282 | 0.0779 |
Mycobacterium tuberculosis | Fatty-acid-CoA synthetase FadD17 (fatty-acid-CoA synthase) (fatty-acid-CoA ligase) | 0.0007 | 0.0038 | 0.0546 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0119 | 0.1571 | 0.4888 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0372 | 0.0335 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0734 | 1 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0025 | 0.0282 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0236 | 0.3174 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0019 | 0.0195 | 0.6421 |
Onchocerca volvulus | 0.0252 | 0.3391 | 1 | |
Mycobacterium tuberculosis | Probable medium chain fatty-acid-CoA ligase FadD14 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0007 | 0.0038 | 0.0546 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.0181 | 0.6071 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0048 | 0.0031 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0372 | 0.1064 |
Trypanosoma brucei | acetyl-CoA synthetase, putative | 0.0007 | 0.0038 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0025 | 0.0282 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.0282 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.0181 | 0.6071 |
Leishmania major | acetyl-CoA synthetase, putative | 0.0007 | 0.0038 | 0.1354 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0025 | 0.0282 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0119 | 0.1571 | 0.4888 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0236 | 0.3174 | 0.3148 |
Plasmodium vivax | SET domain protein, putative | 0.0032 | 0.0372 | 1 |
Mycobacterium tuberculosis | Probable peptide synthetase Nrp (peptide synthase) | 0.0007 | 0.0038 | 0.0546 |
Loa Loa (eye worm) | Smad1 | 0.0008 | 0.0048 | 0.0031 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0025 | 0.0282 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0372 | 0.0335 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0221 | 0.2972 | 0.9354 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0048 | 0.0597 | 0.1782 |
Mycobacterium tuberculosis | Bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ArCP synthetase | 0.0007 | 0.0038 | 0.0546 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0008 | 0.0048 | 0.001 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0048 | 0.001 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0597 | 0.0561 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.0181 | 0.6071 |
Echinococcus granulosus | smad | 0.0008 | 0.0048 | 0.001 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0025 | 0.0282 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0282 | 0.0779 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0008 | 0.0048 | 0.001 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 4 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 9 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 9.04 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 10.56 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 11.17 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 90 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 95 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 1.96 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 4 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 9 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 90 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 95 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.15 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 0.70109 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.